(19)
(11) EP 1 204 452 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.08.2009 Bulletin 2009/33

(45) Mention of the grant of the patent:
21.02.2007 Bulletin 2007/08

(21) Application number: 00950165.1

(22) Date of filing: 13.07.2000
(51) International Patent Classification (IPC): 
B01D 46/04(2006.01)
 B01D 33/56(2006.01)
(86) International application number:
PCT/SE2000/001487
(87) International publication number:
WO 2001/003809 (18.01.2001 Gazette 2001/03)

(54)

FILTER DEVICE

FILTERVORRICHTUNG

DISPOSITIF FILTRANT

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 14.07.1999 SE 9902697

(43) Date of publication of application:
15.05.2002 Bulletin 2002/20

(73) Proprietor: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventor:
  • GLAD, H kan
    S-431 83 Mölndal (SE)


(56) References cited: : 
EP-A- 0 572 356
DE-A1- 2 433 934
US-A- 5 713 972
 EP-A1- 0 870 526
US-A- 3 262 573
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).